$GBCS
SELECTIS HEALTH, INC. Stock $gbcs

$gbcs Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-Q Financial Statement

#000149315223000793 Filed on January 06, 2023

Income Statement

Concept	2023 Q1	2022 Q3	2021 Q3
Revenue	$9.606M	$9.582M	$7.319M
YoY Change	-4.81%	30.92%	15.8%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$11.14M	$9.451M	$6.147M
YoY Change	23.4%	53.74%	29.55%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$438.7K	$453.6K	$435.0K
YoY Change	-2.0%	4.28%	6.93%
% of Gross Profit
Operating Expenses	$11.58M	$9.904M	$6.582M
YoY Change	22.17%	50.47%	27.77%
Operating Profit	-$1.970M	-$322.3K	$736.7K
YoY Change	-419.9%	-143.75%
Interest Expense	$518.3K	$722.2K	-$486.8K
YoY Change	35.57%	-248.36%	-5.65%
% of Operating Profit			-66.08%
Other Income/Expense, Net	$5.996M	-$668.6K	$51.86K
YoY Change	-1648.2%	-1389.33%
Pretax Income	$4.030M	-$990.9K	-$52.99K
YoY Change	1662.29%	1770.03%	-111.25%
Income Tax
% Of Pretax Income
Net Earnings	$4.025M	-$990.9K	-$52.99K
YoY Change	1660.19%	1770.02%	-111.35%
Net Earnings / Revenue	41.9%	-10.34%	-0.72%
Basic Earnings Per Share	$1.32	-$0.33	-$0.02
Diluted Earnings Per Share	$1.32	-$0.33	-$18.76K
COMMON SHARES
Basic Shares Outstanding	3.067M shares	3.067M shares	2.825M shares
Diluted Shares Outstanding	3.055M shares	3.055M shares	2.825M shares

Balance Sheet

Concept	2023 Q1	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.160M	$1.953M	$2.816M
YoY Change	-50.32%	-30.65%	-34.77%
Cash & Equivalents	$1.157M	$2.760M	$2.792M
Short-Term Investments		$24.39K	$24.39K
Other Short-Term Assets	$7.530M	$462.9K	$1.159M
YoY Change	675.21%	-60.07%
Inventory
Prepaid Expenses
Receivables	$2.852M	$3.065M	$4.439M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$11.54M	$5.481M	$8.414M
YoY Change	54.33%	-34.86%	35.27%
LONG-TERM ASSETS
Property, Plant & Equipment	$35.06M	$36.01M	$37.45M
YoY Change	-4.32%	-3.84%	-0.46%
Goodwill	$1.077M	$1.077M
YoY Change	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.040M	$831.7K
YoY Change	16.39%
Total Long-Term Assets	$37.18M	$37.92M	$38.52M
YoY Change	-3.71%	-1.58%	-3.31%
TOTAL ASSETS
Total Short-Term Assets	$11.54M	$5.481M	$8.414M
Total Long-Term Assets	$37.18M	$37.92M	$38.52M
Total Assets	$48.71M	$43.40M	$46.94M
YoY Change	5.7%	-7.54%	1.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.230M	$0.00	$9.990K
YoY Change		-100.0%	0.91%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$900.0K	$150.0K	$275.0K
YoY Change	500.0%	-45.45%
Long-Term Debt Due	$3.934M	$2.050M	$5.287M
YoY Change	14.39%	-61.23%
Total Short-Term Liabilities	$10.07M	$4.686M	$9.017M
YoY Change	32.37%	-48.03%	145.64%
LONG-TERM LIABILITIES
Long-Term Debt	$33.38M	$34.53M	$34.27M
YoY Change	-1.42%	0.76%	-15.29%
Other Long-Term Liabilities	$290.0K	$253.9K	$258.6K
YoY Change	23.36%	-1.82%
Total Long-Term Liabilities	$33.38M	$34.53M	$34.53M
YoY Change	-1.42%	0.0%	-14.65%
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.07M	$4.686M	$9.017M
Total Long-Term Liabilities	$33.38M	$34.53M	$34.53M
Total Liabilities	$43.74M	$40.22M	$43.54M
YoY Change	3.03%	-7.64%	-0.87%
SHAREHOLDERS EQUITY
Retained Earnings	-$9.727M	-$11.54M
YoY Change	-12.29%
Common Stock	$152.7K	$152.7K
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.971M	$3.178M	$3.393M
YoY Change
Total Liabilities & Shareholders Equity	$48.71M	$43.40M	$46.94M
YoY Change	5.7%	-7.54%	1.9%

Cashflow Statement

Concept	2023 Q1	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	$4.025M	-$990.9K	-$52.99K
YoY Change	1660.19%	1770.02%	-111.35%
Depreciation, Depletion And Amortization	$438.7K	$453.6K	$435.0K
YoY Change	-2.0%	4.28%	6.93%
Cash From Operating Activities	-$67.00K	-$752.1K	-$962.4K
YoY Change	-94.42%	-21.85%	-164.27%
INVESTING ACTIVITIES
Capital Expenditures	$42.52K	-$239.7K	-$98.08K
YoY Change	-33.77%	144.37%	-84.48%
Acquisitions
YoY Change
Other Investing Activities			$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$42.52K	-$239.7K	-$98.08K
YoY Change	-33.77%	144.37%	-1.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$107.3K	-135.1K	988.3K
YoY Change	-65.07%	-113.67%	1017.77%
NET CHANGE
Cash From Operating Activities	-$67.00K	-752.1K	-962.4K
Cash From Investing Activities	-$42.52K	-239.7K	-98.08K
Cash From Financing Activities	-$107.3K	-135.1K	988.3K
Net Change In Cash	-$216.9K	-1.127M	-72.12K
YoY Change	-86.35%	1462.47%	-104.85%
FREE CASH FLOW
Cash From Operating Activities	-$67.00K	-$752.1K	-$962.4K
Capital Expenditures	$42.52K	-$239.7K	-$98.08K
Free Cash Flow	-$109.5K	-$512.4K	-$864.3K
YoY Change	-91.34%	-40.72%	-140.59%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2021Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3053970	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2741186	shares
	GBCS	Gain On Forgiveness From Paycheck Protection Program Loan GainOnForgivenessFromPaycheckProtectionProgramLoan		usd
CY2022Q3	GBCS	Gain On Forgiveness From Paycheck Protection Program Loan GainOnForgivenessFromPaycheckProtectionProgramLoan		usd
CY2021Q3	GBCS	Gain On Forgiveness From Paycheck Protection Program Loan GainOnForgivenessFromPaycheckProtectionProgramLoan		usd
	GBCS	Lease Termination Expense LeaseTerminationExpense		usd
CY2022Q3	GBCS	Lease Termination Expense LeaseTerminationExpense		usd
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	UT
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-0340206
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Central Index Key EntityCentralIndexKey	0000727346
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q3	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent		usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent		usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3506719	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	462868	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2022Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2021Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2021Q2	GBCS	Cashless Exercise Of Warrants CashlessExerciseOfWarrants		usd
CY2021Q3	GBCS	Cashless Exercise Of Warrants CashlessExerciseOfWarrants		usd
CY2021Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
	GBCS	Gain On Forgiveness From Paycheck Protection Program Loan GainOnForgivenessFromPaycheckProtectionProgramLoan		usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts		usd
	us-gaap	Share Based Compensation ShareBasedCompensation		usd
	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt		usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest		usd
	GBCS	Proceeds From Debt Discount Warrants Related Parties ProceedsFromDebtDiscountWarrantsRelatedParties		usd
	GBCS	Issuance Of Common Stock For Cashless Exercise Of Warrants IssuanceOfCommonStockForCashlessExerciseOfWarrants		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	GBCS	Conversion Of Preferred Shares ConversionOfPreferredShares		shares
	GBCS	Conversion Of Preferred Shares ConversionOfPreferredShares		shares
CY2022Q3	GBCS	Conversion Of Preferred Shares ConversionOfPreferredShares		shares
CY2021Q3	GBCS	Conversion Of Preferred Shares ConversionOfPreferredShares		shares
	GBCS	Exercise Of Warrants ExerciseOfWarrants		shares
	GBCS	Exercise Of Warrants ExerciseOfWarrants		shares
CY2022Q3	GBCS	Exercise Of Warrants ExerciseOfWarrants		shares
CY2021Q3	GBCS	Exercise Of Warrants ExerciseOfWarrants		shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	0-15415
	dei	Entity Registrant Name EntityRegistrantName	Selectis Health, Inc.
	dei	Entity Address Address Line1 EntityAddressAddressLine1	8480 E Orchard Rd
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Ste 4900
	dei	Entity Address City Or Town EntityAddressCityOrTown	Greenwood Village
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80111
	dei	City Area Code CityAreaCode	720
	dei	Local Phone Number LocalPhoneNumber	680-0808
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3067059	shares
CY2022Q3	us-gaap	Cash Cash	1928472	usd
CY2021Q4	us-gaap	Cash Cash	3939445	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3064919	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	498015	usd
CY2022Q3	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Current DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent	24387	usd
CY2021Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Current DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent	24387	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	5480646	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	150000	usd
CY2022Q3	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	1184	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	1714	usd
CY2022Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	2049750	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	6312562	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	931446	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	7968566	usd
CY2022Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	831687	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	4686203	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11786996	usd
CY2022Q3	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	750000	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	750000	usd
CY2022Q3	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	933737	usd
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	853656	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	36006716	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	37024592	usd
CY2022Q3	us-gaap	Goodwill Goodwill	1076908	usd
CY2021Q4	us-gaap	Goodwill Goodwill	1076908	usd
CY2022Q3	us-gaap	Assets Assets	43395957	usd
CY2021Q4	us-gaap	Assets Assets	46923722	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2478953	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4363917	usd
CY2021Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	21571	usd
CY2022Q3	us-gaap	Dividends Payable Current DividendsPayableCurrent	7500	usd
CY2021Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	7500	usd
CY2022Q3	GBCS	Debt Discount Of Related Parties DebtDiscountOfRelatedParties	0	usd
CY2021Q4	GBCS	Debt Discount Of Related Parties DebtDiscountOfRelatedParties	3234	usd
CY2022Q3	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	150000	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	452593	usd
CY2022Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	34528330	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	31054962	usd
CY2022Q3	us-gaap	Security Deposit Liability SecurityDepositLiability	253899	usd
CY2021Q4	us-gaap	Security Deposit Liability SecurityDepositLiability	229582	usd
CY2022Q3	us-gaap	Liabilities Liabilities	40218432	usd
CY2021Q4	us-gaap	Liabilities Liabilities	43821540	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.05
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.05
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	800000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	800000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3054588	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3054588	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2998362	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2998362	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	152728	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	150168	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	13793300	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	13494394	usd
CY2021Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	435013	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11544503	usd
	us-gaap	Operating Expenses OperatingExpenses	28654203	usd
	us-gaap	Operating Expenses OperatingExpenses	18660565	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11318380	usd
CY2022Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	453608	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-668644	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3177525	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3102182	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	43395957	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	46923722	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	29800207	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19093935	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9581985	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7319055	usd
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	21192559	usd
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	12613896	usd
CY2022Q3	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	7227718	usd
CY2021Q3	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	4413930	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5329475	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4732115	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1970890	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1721292	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	783524	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	28275	usd
CY2022Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	252050	usd
CY2021Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	12142	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1348645	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1286279	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	9904266	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	6582377	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	1146004	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	433370	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-322281	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	736678	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-46466	usd
	us-gaap	Interest Expense InterestExpense	1438629	usd
	us-gaap	Interest Expense InterestExpense	1680540	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	722226	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	486816	usd
	GBCS	Gain On Forgiveness From Paycheck Protection Program Loan GainOnForgivenessFromPaycheckProtectionProgramLoan	675598	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	135468	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	548933	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	53582	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	51856	usd
	GBCS	Lease Termination Expense LeaseTerminationExpense	450427	usd
CY2021Q3	GBCS	Lease Termination Expense LeaseTerminationExpense	354710	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1349627	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-906436	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-789670	usd
	us-gaap	Profit Loss ProfitLoss	-203623	usd
	us-gaap	Profit Loss ProfitLoss	-473066	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-990925	usd
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-52992	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	10650	usd
	us-gaap	Net Income Loss NetIncomeLoss	-203623	usd
	us-gaap	Net Income Loss NetIncomeLoss	-483716	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-990925	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-52992	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	22500	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	22500	usd
CY2022Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	7500	usd
CY2021Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	7500	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-226123	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-506216	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-998425	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-60492	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.33
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.33
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3054588	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2824560	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3053970	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2741186	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3054588	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2824560	shares
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3102182	usd
CY2022Q1	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	7500	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	255000	usd
CY2022Q1	GBCS	Stock Issued During Period Shares Issued For Loss On Forgiveness Of Debt Net StockIssuedDuringPeriodSharesIssuedForLossOnForgivenessOfDebtNet	46466	shares
CY2022Q1	us-gaap	Profit Loss ProfitLoss	37090	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3433238	usd
CY2022Q2	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	7500	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	750212	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4175950	usd
CY2022Q3	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	7500	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-990925	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3177525	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3215939	usd
CY2021Q1	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	7500	usd
CY2021Q1	us-gaap	Profit Loss ProfitLoss	258706	usd
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3467145	usd
CY2021Q2	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	7500	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	18900	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-60000	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-678780	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2739765	usd
CY2021Q3	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	7500	usd
CY2021Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	713625	usd
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-52992	usd
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-52992	usd
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3392898	usd
	us-gaap	Profit Loss ProfitLoss	-203623	usd
	us-gaap	Profit Loss ProfitLoss	-473066	usd
	GBCS	Gain On Forgiveness From Paycheck Protection Program Loan GainOnForgivenessFromPaycheckProtectionProgramLoan	675598	usd
	GBCS	Other Income From Partial Settlement Of Debt OtherIncomeFromPartialSettlementOfDebt	40346	usd
	GBCS	Other Income From Partial Settlement Of Debt OtherIncomeFromPartialSettlementOfDebt	520221	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1348645	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1286279	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	157291	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	783524	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	28275	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	18900	usd
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	341724	usd
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	2535412	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-616540	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-853451	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2837981	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	248337	usd
	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	24317	usd
	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	7000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-650648	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1604764	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	330769	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	493689	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-330769	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-493689	usd
	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	9134102	usd
	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	1075491	usd
	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	8023719	usd
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	22500	usd
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	30000	usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	713625	usd
	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	60000	usd
	GBCS	Proceeds From Debt Discount Warrants Related Parties ProceedsFromDebtDiscountWarrantsRelatedParties	46466	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1051525	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1734008	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2032942	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-364445	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4793101	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3978303	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2760159	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3613858	usd
	us-gaap	Interest Paid Net InterestPaidNet	1438629	usd
	us-gaap	Interest Paid Net InterestPaidNet	1680540	usd
CY2022Q3	us-gaap	Cash Cash	1928472	usd
CY2021Q3	us-gaap	Cash Cash	2791585	usd
CY2022Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	831687	usd
CY2021Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	822273	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2760159	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3613858	usd
	GBCS	Dividends Declared On Series D Preferred Stock DividendsDeclaredOnSeriesDPreferredStock	22500	usd
	GBCS	Dividends Declared On Series D Preferred Stock DividendsDeclaredOnSeriesDPreferredStock	22500	usd
	GBCS	Issuance Of Common Stock For Cashless Exercise Of Warrants IssuanceOfCommonStockForCashlessExerciseOfWarrants	976	usd
	us-gaap	Stock Issued1 StockIssued1	1560	usd
	GBCS	Financing Of Insurance Premiums FinancingOfInsurancePremiums	581393	usd
	GBCS	Financing Of Insurance Premiums FinancingOfInsurancePremiums	507433	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-700000	usd
CY2022Q3	GBCS	Working Capital Deficit WorkingCapitalDeficit	-800000	usd
	GBCS	Net Income Loss Attributable To Diluted Gross NetIncomeLossAttributableToDilutedGross	-226123	usd
CY2021Q3	GBCS	Weighted Average Number Of Diluted Shares Outstanding Except Effect Of Dilutive Securities WeightedAverageNumberOfDilutedSharesOutstandingExceptEffectOfDilutiveSecurities	2824560	shares
	GBCS	Weighted Average Common Shares Outstanding Diluted Effect Of Dilutive Securities WeightedAverageCommonSharesOutstandingDilutedEffectOfDilutiveSecurities	3053970	shares
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_84A_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zGjk9WUBxsYk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_z8HACmStKg3b">Reclassification</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain amounts in the prior period financial statements have been reclassified to conform to the presentation of the current period financial statements. </span>Certain intercompany revenues and expenses were included in revenue and general and administration expenses. These reclassifications had no effect on the previously reported net income.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revisions to Previously Issued Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the six months ending June 30, 2022, the Company identified an error related to the accounting guidance for intercompany revenues and expenses. For the six months ending June 30, 2022 the Company recorded $869,249 of intercompany revenues to healthcare revenue and $869,249 of intercompany expenses in general and administrative expenses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company assessed the materiality of this error on prior period financial statements in accordance with the SEC Staff Accounting Bulletin Number 99, Materiality, and ASC 250-10, Accounting Changes and Error Corrections. The error did not have any effect on the Company’s previously reported Condensed Consolidated Statements of Cash Flows and Condensed Consolidated Statements of Shareholder’s Deficit. The Company determined that this error was not material to the financial statements for the six months ended June 30, 2022. The Company decided to correct this immaterial error as revision to previously issued financial statement and has revised the June 30, 2022 financial statements presented herein.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ChangeInAccountingEstimateTextBlock_gL3CIAETB-RN_zWH4uTmSu9d2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The below tables summarize the effect of the revisions on the affected line items within the Condensed Consolidated Statement of Operations for the six months ended June 30, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_8B4_zJ2BmHXp7xm7" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF RESTATEMENT</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" id="xdx_305_134_z6MxRDsbmVLe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SCHEDULE OF RESTATEMENT (Details)"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20220101__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zo0yStqS7aae" style="border-bottom: Black 1.5pt solid; text-align: center">As previously reported</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20220101__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zlFnK70lgzAa" style="border-bottom: Black 1.5pt solid; text-align: center">Revision adjustments</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20220101__20220630__srt--RestatementAxis__custom--AdjustedMember_zEr0uvmydCGf" style="border-bottom: Black 1.5pt solid; text-align: center">As revised</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="10" style="text-align: center">Six Months Ended</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center">June 30, 2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">As previously reported</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Revision adjustments</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">As revised</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_409_eus-gaap--RevenuesAbstract_zXCmaWAcPfwf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--RentalMember_ze2wUNhu9Z9d" style="vertical-align: bottom; background-color: White"> <td style="width: 46%; text-align: left">Rental Revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">311,063</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0795">-</span></span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">311,063</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__us-gaap--HealthCareMember_zXq4EdiNanj2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Healthcare Revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18,642,051</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(869,249</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17,772,802</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--HealthcareGrantRevenueMember_z6p6jz9Whqb3" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Healthcare Grant Revenue</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,603,659</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0803">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,603,659</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--Revenues_zGom5usll4S9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Total Revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21,556,773</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(869,249</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">20,987,524</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--OperatingExpensesAbstract_iB_zQ0l3nHnYJl7" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">Expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--OtherCostAndExpenseOperating_i01_zttnirhwL0ti" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Property Taxes, Insurance and Other Operating</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,964,841</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,964,841</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--GeneralAndAdministrativeExpense_i01_zPkRfNvLYKOc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">General and Administrative</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,227,834</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(869,249</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,358,585</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--ProvisionForDoubtfulAccounts_i01_zWO0r6OcTuZa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Provision for Bad Debts</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">531,474</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">531,474</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--DepreciationDepletionAndAmortization_i01_zSfGTAkr8MP" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Depreciation and Amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">895,037</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">895,037</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--OperatingExpenses_i01T_z4fc9qthUhj7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Total Expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">19,619,186</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(869,249</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">18,749,937</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--OperatingIncomeLoss_iT_zkJ5kXZSzUyd" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">Income from Operations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,937,587</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,937,587</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_zAxuWEwoDhHf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Other (Income) Expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--GainsLossesOnExtinguishmentOfDebt_i01_zqEZ2zp70Cr7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Loss (Gain) on Extinguishment of Debt</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">46,466</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">46,466</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--InterestExpense_i01_zHc57tXO6xQk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Interest Expense, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">716,403</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">716,403</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--GainOnForgivenessOfPppLoan_i01_zOpIienisye2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Gain on Forgiveness of PPP Loan</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0850">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0852">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--OtherNonoperatingIncomeExpense_i01_zh106GS6CBah" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Other Income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(81,886</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(81,886</td><td style="text-align: left">)</td></tr> <tr id="xdx_40F_ecustom--LeaseTerminationExpense_i01_zwGDaiCR1L19" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Lease Termination Expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0858">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0860">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--NonoperatingIncomeExpense_i01T_zOzU9LlJtk8c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Total Other (Income) Expense</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">680,983</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">680,983</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--ProfitLoss_zWnccVCTxLic" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">Net Income (Loss)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,256,604</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,256,604</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A2_zfMRs2lIEYo8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the preparation of the nine months ending September 30, 2022, financial statements management became aware of misstatements in the financial statements of $<span id="xdx_908_ecustom--MisstatementAdjustmentErrorAmount_c20220101__20220331_zbuOymVzqbRb" title="Misstatement adjustment amount">191,589</span> and $<span id="xdx_909_ecustom--MisstatementAdjustmentErrorAmount_c20220101__20220630_zhdeJFEHMSLc" title="Misstatement adjustment amount">469,302</span> of healthcare revenue and accounts receivable reported during the three and six month periods ended March 31, 2022 and June 30, 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company determined that cash payments received from a Medicare B bad debt reimbursement program were recorded directly to revenue rather than a reduction to the account receivable account to which the receivables were recorded, causing both revenue and receivables to be overstated at each reporting periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_C0E_gL3CIAETB-RN_zI8brrK1AxW5"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <div id="xdx_C0D_gL3CIAETB-RN_zExpmZxakwp8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The below table summarizes the effect of the revisions on the affected line items within the Condensed Consolidated Statement of Operations and Condensed Consolidated Balance Sheet for the period ended March 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_304_132_zElHP0xBAfnb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SCHEDULE OF RESTATEMENT (Details)"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20220101__20220331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z1SbzkqmHjF8" style="border-bottom: Black 1.5pt solid; text-align: center">Reported</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20220101__20220331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zfayNWhHwNwg" style="border-bottom: Black 1.5pt solid; text-align: center">Revision adjustments</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20220101__20220331__srt--RestatementAxis__custom--AdjustedMember_zTSVpaeIiGBl" style="border-bottom: Black 1.5pt solid; text-align: center">Adjusted</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="13" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three months ended March 31, 2022</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Reported</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Revision adjustments</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Adjusted</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">P&L Analysis</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zcVtLx4nV6Y" style="vertical-align: bottom; background-color: White"> <td style="width: 46%; text-align: left">Total Revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">10,091,006</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(191,589</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">9,899,417</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__us-gaap--HealthCareMember_zloUldO4jjyi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Healthcare Revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,367,854</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">(191,589</p></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,176,265</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_ecustom--OperatingIncome_zmsz7YVzE3j8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Operating Income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">615,396</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(191,589</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">423,807</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--NetIncomeLoss_zO2rplnmTLTe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Net Income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">228,679</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(191,589</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">37,090</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--EarningsPerShareBasic_z1ueYmpDi8Nb" style="vertical-align: bottom; background-color: White"> <td>EPS</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.07</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.01</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zS1g6HO1U97l" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>WASO</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,052,769</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,052,769</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Balance Sheet Analysis</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accounts Receivable</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--AccountsReceivableNetCurrent_iI_c20220331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_ztDPtqoRPxEg" style="text-align: right" title="Accounts receivable">4,168,272</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><p id="xdx_984_eus-gaap--AccountsReceivableNetCurrent_iI_c20220331__srt--RestatementAxis__srt--RestatementAdjustmentMember_ze6YakUVyZK1" style="font: 10pt Times New Roman, Times, Serif; margin: 0" title="Accounts receivable">(191,589</p></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--AccountsReceivableNetCurrent_iI_c20220331__srt--RestatementAxis__custom--AdjustedMember_z1rOlgvfCh0l" style="text-align: right" title="Accounts receivable">3,976,683</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Current Assets</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--AssetsCurrent_iI_c20220331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zxJRNbxGp047" style="text-align: right" title="Current Assets">7,474,534</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p id="xdx_987_eus-gaap--AssetsCurrent_iI_c20220331__srt--RestatementAxis__srt--RestatementAdjustmentMember_z7z4EMJKcv4h" style="font: 10pt Times New Roman, Times, Serif; margin: 0" title="Current Assets">(191,589</p></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--AssetsCurrent_iI_c20220331__srt--RestatementAxis__custom--AdjustedMember_zx88pE3hWUc7" style="text-align: right" title="Current Assets">7,282,945</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total Assets</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--Assets_iI_c20220331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z5l2LyIwHcbg" style="text-align: right" title="Assets">46,086,051</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p id="xdx_987_eus-gaap--Assets_iI_c20220331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zNQX1isfl77k" style="font: 10pt Times New Roman, Times, Serif; margin: 0" title="Assets">(191,589</p></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--Assets_iI_c20220331__srt--RestatementAxis__custom--AdjustedMember_zp1PSm3007C9" style="text-align: right" title="Assets">45,894,462</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Working Capital</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--WorkingCapital_iI_c20220331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zesgVmXsdjMc" style="text-align: right" title="Working Capital">38,478,308</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p id="xdx_98F_ecustom--WorkingCapital_iI_c20220331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zyZITZnBVOv9" style="font: 10pt Times New Roman, Times, Serif; margin: 0" title="Working Capital">(191,589</p></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--WorkingCapital_iI_c20220331__srt--RestatementAxis__custom--AdjustedMember_zG2s4kQrSfBj" style="text-align: right" title="Working Capital">38,286,719</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accumulated Deficit</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_c20220331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zsz9dXGPfPtl" style="text-align: right" title="Accumulated Deficit">(11,089,701</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"/><td id="xdx_987_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_c20220331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zpriVaOMnO2g" style="text-align: right" title="Accumulated Deficit">(191,589</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_c20220331__srt--RestatementAxis__custom--AdjustedMember_z91vircFg0Df" style="text-align: right" title="Accumulated Deficit">(11,281,290</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total Equity</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--StockholdersEquity_iI_c20220331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zUCPQnwP1zGc" style="text-align: right" title="Total Equity">3,632,327</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p id="xdx_98E_eus-gaap--StockholdersEquity_iI_c20220331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zIVuLjVRjktf" style="font: 10pt Times New Roman, Times, Serif; margin: 0" title="Total Equity">(191,589</p></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--StockholdersEquity_iI_c20220331__srt--RestatementAxis__custom--AdjustedMember_zBQOcTiXSqZi" style="text-align: right" title="Total Equity">3,440,738</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The below table summarizes the effect of the revisions on the affected line items within the Condensed Consolidated Statement of Operations and Condensed Consolidated Balance Sheet for the period ended June 30, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20210101__20211231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zNq9HZBiArA7" style="border-bottom: Black 1.5pt solid; text-align: center">YTD Reported</td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20210101__20211231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zaChOev8lacc" style="text-align: center">Revision adjustment</td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20210101__20211231__srt--RestatementAxis__custom--AdjustedMember_zismwMqI1EY6" style="border-bottom: Black 1.5pt solid; text-align: center">YTD Adjusted</td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20220101__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z5fuOw490ogf" style="border-bottom: Black 1.5pt solid; text-align: center">QTD Reported</td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20220101__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember_z87jMCx2IxV3" style="text-align: center">Revision adjustment</td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20220101__20220630__srt--RestatementAxis__custom--AdjustedMember_z9fy85EDxmsb" style="border-bottom: Black 1.5pt solid; text-align: center">QTD Adjusted</td><td style="text-align: center; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="25" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three and six months ended June 30, 2022</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">YTD Reported</td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Revision adjustment</td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">YTD Adjusted</td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">QTD Reported</td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Revision adjustment</td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">QTD Adjusted</td><td style="text-align: center; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">P&L analysis</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_z6jCwLyoSSEh" style="vertical-align: bottom; background-color: White"> <td style="width: 28%; text-align: left">Total Revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">20,687,524</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">(469,302</p></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">20,218,222</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">10,596,518</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">(277,713</p><span style="font-family: Times New Roman, Times, Serif"/></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">10,318,805</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__us-gaap--HealthCareMember_zg7vqr4rUFy4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Healthcare Revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17,772,802</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(469,302</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17,303,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,404,948</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(277,713</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,127,235</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--OperatingIncome_znzMzm1z3hg9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Operating Income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,937,587</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">(469,302</p></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,468,285</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,321,651</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">(277,713</p></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,043,938</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--NetIncomeLoss_zQHxZ05l4Mcf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Net Income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,256,604</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(469,302</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">787,302</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,027,925</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">(277,713</p></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">750,212</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--EarningsPerShareBasic_zagAYXQ7cVG5" style="vertical-align: bottom; background-color: White"> <td>EPS</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.42</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.26</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.34</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.25</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zASX0j4BJhLe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>WASO</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,998,361</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,998,361</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,054,627</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,054,627</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Balance Sheet analysis</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accounts Receivable</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--AccountsReceivableNetCurrent_iI_c20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z5ZCFbRMxG41" style="text-align: right">5,167,862</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><p id="xdx_981_eus-gaap--AccountsReceivableNetCurrent_iI_c20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zJQHBqQA9hF4" style="font: 10pt Times New Roman, Times, Serif; margin: 0">(469,302</p><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--AccountsReceivableNetCurrent_iI_c20220630__srt--RestatementAxis__custom--AdjustedMember_zQ3CuS5Y5uR6" style="text-align: right">4,698,560</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Current Assets</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--AssetsCurrent_iI_c20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zVDnXzo5Pwy8" style="text-align: right">8,789,109</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p id="xdx_988_eus-gaap--AssetsCurrent_iI_c20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zH1oBjo1CFz8" style="font: 10pt Times New Roman, Times, Serif; margin: 0">(469,302</p></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--AssetsCurrent_iI_c20220630__srt--RestatementAxis__custom--AdjustedMember_zSzQPYOOZvcl" style="text-align: right">8,319,807</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total Assets</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--Assets_iI_c20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zMiZgmZmtpC6" style="text-align: right">47,014,470</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p id="xdx_985_eus-gaap--Assets_iI_c20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zvbATEu7gj8f" style="font: 10pt Times New Roman, Times, Serif; margin: 0">(469,302</p></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--Assets_iI_c20220630__srt--RestatementAxis__custom--AdjustedMember_zD2uOg84SDT9" style="text-align: right">46,545,168</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Working Capital</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--WorkingCapital_iI_c20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z8FMR2THZSIc" style="text-align: right">32,534,605</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p id="xdx_98F_ecustom--WorkingCapital_iI_c20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zkm5iUl2kNkl" style="font: 10pt Times New Roman, Times, Serif; margin: 0">(469,302</p></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--WorkingCapital_iI_c20220630__srt--RestatementAxis__custom--AdjustedMember_zio0gcX3KMB6" style="text-align: right">32,065,303</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accumulated Deficit</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_c20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zbsDDMxIfLMf" style="text-align: right">(10,061,776</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_c20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zo0CNIMItFGk" style="text-align: right">(469,302</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_c20220630__srt--RestatementAxis__custom--AdjustedMember_zNaYjLttaYOk" style="text-align: right">(10,531,078</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total Equity</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--StockholdersEquity_iI_c20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zdLX2mevFDTf" style="text-align: right">4,660,252</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p id="xdx_98C_eus-gaap--StockholdersEquity_iI_c20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zesYCrItTMO3" style="font: 10pt Times New Roman, Times, Serif; margin: 0">(469,302</p></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--StockholdersEquity_iI_c20220630__srt--RestatementAxis__custom--AdjustedMember_zPA2uHgS4Byf" style="text-align: right">4,190,950</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> </table> </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_C08_gL3CIAETB-RN_znzaR29cVm7i"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2022Q1	GBCS	Misstatement Adjustment Error Amount MisstatementAdjustmentErrorAmount	191589	usd
	GBCS	Misstatement Adjustment Error Amount MisstatementAdjustmentErrorAmount	469302	usd
	us-gaap	Net Income Loss NetIncomeLoss	-203623	usd
	us-gaap	Net Income Loss NetIncomeLoss	-483716	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-990925	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-52992	usd
	GBCS	Preferred Stock Dividends And Other Adjustments Basic PreferredStockDividendsAndOtherAdjustmentsBasic	-22500	usd
	GBCS	Preferred Stock Dividends And Other Adjustments Basic PreferredStockDividendsAndOtherAdjustmentsBasic	-22500	usd
CY2022Q3	GBCS	Preferred Stock Dividends And Other Adjustments Basic PreferredStockDividendsAndOtherAdjustmentsBasic	-7500	usd
CY2021Q3	GBCS	Preferred Stock Dividends And Other Adjustments Basic PreferredStockDividendsAndOtherAdjustmentsBasic	-7500	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-226123	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-506216	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-998425	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-60492	usd
	GBCS	Net Income Loss Attributable To Diluted Gross NetIncomeLossAttributableToDilutedGross	-506216	usd
CY2022Q3	GBCS	Net Income Loss Attributable To Diluted Gross NetIncomeLossAttributableToDilutedGross	-998425	usd
CY2021Q3	GBCS	Net Income Loss Attributable To Diluted Gross NetIncomeLossAttributableToDilutedGross	-60492	usd
	GBCS	Preferred Stock Dividends And Other Adjustments Diluted PreferredStockDividendsAndOtherAdjustmentsDiluted	-22500	usd
	GBCS	Preferred Stock Dividends And Other Adjustments Diluted PreferredStockDividendsAndOtherAdjustmentsDiluted	-22500	usd
CY2022Q3	GBCS	Preferred Stock Dividends And Other Adjustments Diluted PreferredStockDividendsAndOtherAdjustmentsDiluted	-7500	usd
CY2021Q3	GBCS	Preferred Stock Dividends And Other Adjustments Diluted PreferredStockDividendsAndOtherAdjustmentsDiluted	-7500	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-203623	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-483716	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-990925	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-52992	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3053970	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2741186	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3054588	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2824560	shares
	GBCS	Weighted Average Number Of Diluted Shares Outstanding Except Effect Of Dilutive Securities WeightedAverageNumberOfDilutedSharesOutstandingExceptEffectOfDilutiveSecurities	3053970	shares
	GBCS	Weighted Average Number Of Diluted Shares Outstanding Except Effect Of Dilutive Securities WeightedAverageNumberOfDilutedSharesOutstandingExceptEffectOfDilutiveSecurities	2741186	shares
CY2022Q3	GBCS	Weighted Average Number Of Diluted Shares Outstanding Except Effect Of Dilutive Securities WeightedAverageNumberOfDilutedSharesOutstandingExceptEffectOfDilutiveSecurities	3054588	shares
	GBCS	Weighted Average Common Shares Outstanding Diluted Effect Of Dilutive Securities WeightedAverageCommonSharesOutstandingDilutedEffectOfDilutiveSecurities	2741186	shares
CY2022Q3	GBCS	Weighted Average Common Shares Outstanding Diluted Effect Of Dilutive Securities WeightedAverageCommonSharesOutstandingDilutedEffectOfDilutiveSecurities	3054588	shares
CY2021Q3	GBCS	Weighted Average Common Shares Outstanding Diluted Effect Of Dilutive Securities WeightedAverageCommonSharesOutstandingDilutedEffectOfDilutiveSecurities	2824560	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.33
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.33
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	47774772	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	49004003	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11768056	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10419411	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	36006716	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	37024592	usd
	us-gaap	Depreciation Depreciation	1348645	usd
	us-gaap	Depreciation Depreciation	1286279	usd
CY2022Q3	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Current DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent	24387	usd
CY2021Q4	us-gaap	Held To Maturity Securities Debt Maturities Single Maturity Date Fair Value HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue	24387	usd
CY2022Q3	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	38346641	usd
CY2021Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	39510595	usd
CY2022Q3	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	868561	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	1243071	usd
CY2022Q3	GBCS	Debt Longterm And Shortterm Combined Net Amount DebtLongtermAndShorttermCombinedNetAmount	37478080	usd
CY2021Q4	GBCS	Debt Longterm And Shortterm Combined Net Amount DebtLongtermAndShorttermCombinedNetAmount	38267524	usd
CY2022Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	2049750	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	6312562	usd
CY2022Q3	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	150000	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	150000	usd
CY2022Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	34528330	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	31054962	usd
CY2022Q3	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	750000	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	750000	usd
CY2022Q3	GBCS	Incremental Increase In Fair Value Of Debt Discount IncrementalIncreaseInFairValueOfDebtDiscount	844425	usd
	us-gaap	Repayments Of First Mortgage Bond RepaymentsOfFirstMortgageBond	118716	usd
CY2021Q3	us-gaap	Debt Instrument Maturity Date Description DebtInstrumentMaturityDateDescription	June, 2027
CY2021Q3	us-gaap	Debt Instrument Term DebtInstrumentTerm	P35Y
CY2021Q3	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0238	pure
CY2022Q3	us-gaap	Notes Payable NotesPayable	1025000	usd
CY2021Q4	us-gaap	Notes Payable NotesPayable	2055000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	931446	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	156870	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	635026	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	643401	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	651954	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	660665	usd
CY2022Q3	GBCS	Lessee Operating Lease Liability Payments Due Year Four And There After LesseeOperatingLeaseLiabilityPaymentsDueYearFourAndThereAfter	55116	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2803032	usd

Files In Submission

Name	View Source	Status
0001493152-23-000793-index-headers.html	Edgar Link	pending
0001493152-23-000793-index.html	Edgar Link	pending
0001493152-23-000793.txt	Edgar Link	pending
0001493152-23-000793-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
gbcs-20220930.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
gbcs-20220930_cal.xml	Edgar Link	unprocessable
gbcs-20220930_lab.xml	Edgar Link	unprocessable
gbcs-20220930_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
gbcs-20220930_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GBCS
SELECTIS HEALTH, INC. Stock $gbcs

2023 Q1 Form 10-Q Financial Statement

#000149315223000793 Filed on January 06, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GBCS SELECTIS HEALTH, INC. Stock $gbcs

2023 Q1 Form 10-Q Financial Statement

#000149315223000793 Filed on January 06, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GBCS
SELECTIS HEALTH, INC. Stock $gbcs